No Data
No Data
Investors Appear Satisfied With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Prospects
When close to half the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3.3x, you may consider Cytek Biosciences, Inc. (NASDAQ:CTKB) as a
Express News | Cytek Biosciences Announces $50 Million Stock Repurchase Program
Cytek Biosciences to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Health care stocks were leaning lower premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) retreated 0.6% and the iShares Biotechnology ETF (IBB) declined 0.2% recently. SurModics (SRD
Express News | Cytek Biosciences Says Its 1-laser And 2-laser 6-color TBNK Reagent Cocktails Have Received China NMPA Approval For Clinical Diagnostic Use
Express News | 1-Laser and 2-Laser 6-Color Tbnk Reagents From Cytek® Biosciences Approved for Clinical Use in China
No Data